DURHAM – TeraRecon, an artificial intelligence startup in Durham, is merging with Boston-based ConcertAI, the companies announced early Tuesday.
Financial terms were not disclosed.
TeraRecon an advanced visualization and solution provider in the field of medical imaging, whose technology uses artificial intelligence the company says enables enhanced patient care
The combined company will maintain a presence in Durham, ConcertAI noted in a press released.
In 2020, TeraReconwas acquired by SymphonyAI.
“We are excited to announce that we are now a @ConcertAI company!” TeraRecon tweeted Tuesday.
“Our solutions will be integrated with their leading enterprise AI and Real-World Evidence to further support accelerated insights and outcomes for patients.”
Crunchbase defines ConcertAI as “an AI-powered SaaS data company in healthcare that develops medical research tool in oncology.” It has raised more than $150 million from investors, Crunchbase notes.
TeraRecon, with a top ranked AI-powered medical imaging product, appoints new president
